|
Melissa Carpenter, Ph.D., was appointed Novocell’s vice president of research and development in 2006 after having served its subsidiary, CyThera, as its director of stem cell research since 2004. Dr. Carpenter has been involved with human embryonic stem cell (hESC) research since the field was established. Prior to joining CyThera, Dr. Carpenter held the position of principal investigator and scientist at the Robarts Research Institute and associate professor, Faculty of Medicine at the University of Western Ontario. At Robarts, Dr. Carpenter’s laboratory focused on the epigenetic status of hESCs and the signaling pathways involved in self-renewal. Before relocating to Canada, Dr. Carpenter was director of stem cell biology at Geron Corporation where she was responsible for managing discovery research programs aimed at developing therapies for degenerative diseases. Prior to Geron, Dr. Carpenter performed stem cell research at Cytotherapeutics. Dr. Carpenter received a Ph.D. in neuroscience from the University of California, Irvine and completed postdoctoral work at Colorado State University and Immunex Corporation. She is credited with numerous publications and patents in the stem cell field. | 